Restricted accessResearch articleFirst published online 2012-9
Intestinal Adaptation Is Stimulated by Partial Enteral Nutrition Supplemented With the Prebiotic Short-Chain Fructooligosaccharide in a Neonatal Intestinal Failure Piglet Model
Butyrate has been shown to stimulate intestinal adaptation when added to parenteral nutrition (PN) following small bowel resection but is not available in current PN formulations. The authors hypothesized that pre- and probiotic administration may be a clinically feasible method to administer butyrate and stimulate intestinal adaptation.
Methods and Materials:
Neonatal piglets (48 hours old, n = 87) underwent placement of a jugular catheter and an 80% jejunoileal resection and were randomized to one of the following treatment groups: control (20% standard enteral nutrition/80% standard PN), control plus prebiotic (10 g/L short-chain fructooligosaccharides [scFOS]), control plus probiotic (1 × 109 CFU Lactobacillus rhamnosus GG [LGG]), or control plus synbiotic (scFOS + LGG). Animals received infusions for 24 hours, 3 days, or 7 days, and markers of intestinal adaptation were assessed.
Results:
Prebiotic treatment increased ileal mucosa weight compared with all other treatments (P = .017) and ileal protein compared with control (P = .049), regardless of day. Ileal villus length increased in the prebiotic and synbiotic group (P = .011), regardless of day, specifically due to an increase in epithelial proliferation (P = .003). In the 7-day prebiotic group, peptide transport was upregulated in the jejunum (P = .026), whereas glutamine transport was increased in both the jejunum and colon (P = .001 and .003, respectively).
Conclusions:
Prebiotic and/or synbiotic supplementation resulted in enhanced structure and function throughout the residual intestine. Identification of a synergistic prebiotic and probiotic combination may enhance the promising results obtained with prebiotic treatment alone.
GouletORuemmeleF. Causes and management of intestinal failure in children. Gastroenterology. 2006;130(2)(suppl):S16-S28.
4.
DudleyMAWykesLJDudleyAWJr. Parenteral nutrition selectively decreases protein synthesis in the small intestine. Am J Pshysiol. 1998;274(1, pt 1):G131-G137.
5.
SigaletDLLeesGMAherneF. The physiology of adaptation to small bowel resection in the pig: an integrated study of morphological and functional changes. J Pediatr Surg. 1990;25(6):650-657.
6.
WilmoreDWDudrickSJDalyJMVarsHM. The role of nutrition in the adaptation of the small intestine after massive resection. Surg Gynecol Obstet. 1971;132(4):673-680.
7.
KaufmanSSPehlivanovaMFennellyEM. Predicting liver failure in parenteral nutrition–dependent short bowel syndrome of infancy. J Pediatr. 2010;156(4):580-5.e1.
8.
RossiLKadambaPHugossonCDe VolEBHabibZAl-NassarS. Pediatric short bowel syndrome: adaptation after massive small bowel resection. J Pediatr Gastroenterol Nutr. 2007;45(2):213-221.
9.
WalesPWde SilvaNKimJHLecceLSandhuAMooreAM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg. 2005;40(5):755-762.
10.
CummingsJH. Colonic absorption: the importance of short chain fatty acids in man. Scand J Gastroenterol Suppl. 1984;93:89-99.
11.
KorudaMJRolandelliRHBlissDZHastingsJRombeauJLSettleRG. Parenteral nutrition supplemented with short-chain fatty acids: effect on the small-bowel mucosa in normal rats. Am J Clin Nutr. 1990;51(4):685-689.
12.
KorudaMJRolandelliRHSettleRGZimmaroDMRombeauJL. Effect of parenteral nutrition supplemented with short-chain fatty acids on adaptation to massive small bowel resection. Gastroenterology. 1988;95(3):715-720.
13.
TappendenKAThomsonABWildGEMcBurneyMI. Short-chain fatty acids increase proglucagon and ornithine decarboxylase messenger RNAs after intestinal resection in rats. JPEN J Parenter Enteral Nutr. 1996;20(5):357-362.
14.
BartholomeALAlbinDMBakerDHHolstJJTappendenKA. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr. 2004;28(4):210-222; discussion 22-223.
15.
TappendenKAThomsonABWildGEMcBurneyMI. Short-chain fatty acid–supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology. 1997;112(3):792-802.
16.
GibsonGRProbertHMLooJVRastallRARoberfroidMB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. 2004;17(2):259-275.
17.
WykesLJBallROPencharzPB. Development and validation of a total parenteral nutrition model in the neonatal piglet. J Nutr. 1993;123(7):1248-1259.
18.
MoughanPJBirtlesMJCranwellPDSmithWCPedrazaM. The piglet as a model animal for studying aspects of digestion and absorption in milk-fed human infants. World Rev Nutr Diet. 1992;67:40-113.
19.
ShovellerAKBruntonJABrandOPencharzPBBallRO. N-acetylcysteine is a highly available precursor for cysteine in the neonatal piglet receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 2006;30(2):133-142.
20.
TurnerJMWalesPWNationPN. Novel neonatal piglet models of surgical short bowel syndrome with intestinal failure. J Pediatr Gastroenterol Nutr. 2011;52(1):9-16.
21.
TappendenKADrozdowskiLAThomsonABMcBurneyMI. Short-chain fatty acid–supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats. Am J Clin Nutr. 1998;68(1):118-125.
22.
National Research Council. Nutrient Requirements of Swine. Washington, DC: National Academies Press; 1999.
LattSAStettenG. Spectral studies on 33258 Hoechst and related bisbenzimidazole dyes useful for fluorescent detection of deoxyribonucleic acid synthesis. J Histochem Cytochem. 1976;24(1):24-33.
25.
LowryOHRosebroughNJFarrALRandallRJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193(1):265-275.
26.
MesserMDahlqvistA. A one-step ultramicro method for the assay of intestinal disaccharidases. Anal Biochem. 1966;14(3):376-392.
27.
KlesKAWalligMATappendenKA. Luminal nutrients exacerbate intestinal hypoxia in the hypoperfused jejunum. JPEN J Parenter Enteral Nutr. 2001;25(5):246-253.
28.
HartmannBJohnsenAHØrskovCAdelhorstKThimLHolstJJ. Structure, measurement, and secretion of human glucagon-like peptide-2. Peptides. 2000;21(1):73-80.
29.
MogilnerJGSrugoILurieM. Effect of probiotics on intestinal regrowth and bacterial translocation after massive small bowel resection in a rat. J Pediatr Surg. 2007;42(8):1365-1371.
30.
O’BrienDPNelsonLAKempCJ. Intestinal permeability and bacterial translocation are uncoupled after small bowel resection. J Pediatr Surg. 2002;37(3):390-394.
31.
MacFieJReddyBSGattMJainPKSowdiRMitchellCJ. Bacterial translocation studied in 927 patients over 13 years. Br J Surg. 2006;93(1):87-93.
32.
WildhaberBEYangHSpencerAUDrongowskiRATeitelbaumDH. Lack of enteral nutrition—effects on the intestinal immune system. J Surg Res. 2005;123(1):8-16.
33.
FlickingerEAWolfBWGarlebKA. Glucose-based oligosaccharides exhibit different in vitro fermentation patterns and affect in vivo apparent nutrient digestibility and microbial populations in dogs. J Nutr. 2000;130(5):1267-1273.
34.
Correa-MatosNJDonovanSMIsaacsonREGaskinsHRWhiteBATappendenKA. Fermentable fiber reduces recovery time and improves intestinal function in piglets following Salmonella typhimurium infection. J Nutr. 2003;133(6):1845-1852.
35.
ReidGSandersMEGaskinsHR. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol. 2003;37(2):105-118.
36.
ScholtensPAAllesMSBindelsJGvan der LindeEGTolboomJJKnolJ. Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. J Pediatr Gastroenterol Nutr. 2006;42(5):553-559.
37.
GronlundMMLehtonenOPKeroPSaxelinMSalminenS. Lactobacillus GG supplementation does not reduce faecal colonization of Klebsiella oxytoca in preterm infants. Acta Paediatr. 1997;86(7):785-786.
38.
AgarwalRSharmaNChaudhryR. Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr. 2003;36(3):397-402.
39.
ManzoniPMaestriALeonessaMMostertMFarinaDGomiratoG. Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates. J Perinatol. 2006;26(1):23-30.
40.
RougeCPiloquetHButelMJ. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2009;89(6):1828-1835.
41.
ManzoniPListaGGalloE. Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Hum Dev. 2011;87(suppl):S35-S38.
42.
SakataTKojimaTFujiedaMTakahashiMMichibataT. Influences of probiotic bacteria on organic acid production by pig caecal bacteria in vitro. Proc Nutr Soc. 2003;62(1):73-80.
43.
KonstantinovSRAwatiAAWilliamsBA. Post-natal development of the porcine microbiota composition and activities. Environ Microbiol. 2006;8(7):1191-1199.
44.
SwansonKSGrieshopCMFlickingerEA. Fructooligosaccharides and Lactobacillus acidophilus modify gut microbial populations, total tract nutrient digestibilities and fecal protein catabolite concentrations in healthy adult dogs. J Nutr. 2002;132(12):3721-3731.
45.
GohYJZhangCBensonAKSchlegelVLeeJHHutkinsRW. Identification of a putative operon involved in fructooligosaccharide utilization byLactobacillus paracasei. Appl Environ Microbiol. 2006;72(12):7518-7530.
46.
DowlingRHBoothCC. Structural and functional changes following small intestinal resection in the rat. Clin Sci. 1967;32(1):139-149.
47.
ThompsonJSFergusonDC. Effect of the distal remnant on ileal adaptation. J Gastrointest Surg. 2000;4(4):430-434.
48.
MadaraJLPappenheimerJR. Structural basis for physiological regulation of paracellular pathways in intestinal epithelia. J Membr Biol. 1987;100(2):149-164.
49.
TurnerJRBlackEDWardJ. Transepithelial resistance can be regulated by the intestinal brush-border na(+)/H(+) exchanger NHE3. Am J Physiol Cell Physiol. 2000;279(6):C1918-C1924.
50.
CummingsJHGibsonGRMacfarlaneGT. Quantitative estimates of fermentation in the hind gut of man. Acta Vet Scand Suppl. 1989;86:76-82.
51.
FlorentCFlourieBLeblondARautureauMBernierJJRambaudJC. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest. 1985;75(2):608-613.
52.
BrietFFlourieBAchourLMaurelMRambaudJCMessingB. Bacterial adaptation in patients with short bowel and colon in continuity. Gastroenterology. 1995;109(5):1446-1453.
53.
MessingBCrennPBeauPBoutron-RuaultMCRambaudJCMatuchanskyC. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology. 1999;117(5):1043-1050.
54.
NightingaleJMLennard-JonesJEGertnerDJWoodSRBartramCI. Colonic preservation reduces need for parenteral therapy, increases incidence of renal stones, but does not change high prevalence of gall stones in patients with a short bowel. Gut. 1992;33(11):1493-1497.
55.
JolyFMayeurCMessingB. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2009;297(1):G116-G123.
56.
ZieglerTRFernandez-EstivarizCGuLH. Distribution of the H+/peptide transporter PepT1 in human intestine: up-regulated expression in the colonic mucosa of patients with short-bowel syndrome. Am J Clin Nutr. 2002;75(5):922-930.
57.
MartinGRWallaceLESigaletDL. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2004;286(6):G964-G972.
58.
SigaletDLBawazirOMartinGR. Glucagon-like peptide-2 induces a specific pattern of adaptation in remnant jejunum. Dig Dis Sci. 2006;51(9):1557-1566.
59.
LiuXNelsonDWHolstJJNeyDM. Synergistic effect of supplemental enteral nutrients and exogenous glucagon-like peptide 2 on intestinal adaptation in a rat model of short bowel syndrome. Am J Clin Nutr. 2006;84(5):1142-1150.
JeppesenPBHartmannBThulesenJ. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology. 2001;120(4):806-815.
62.
JeppesenPBGilroyRPertkiewiczMAllardJPMessingBO’KeefeSJ. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011;60(7):902-914.
63.
JeppesenPBLundPGottschalckIB. Short bowel patients treated for two years with glucagon-like peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function. Gastroenterol Res Pract. 2009;2009:616054.
64.
JeppesenPBLundPGottschalckIB. Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life. Gastroenterol Res Pract. 2009;2009:425759.
65.
ThulesenJHartmannBNielsenCHolstJJPoulsenSS. Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre. Gut. 1999;45(5):672-678.
66.
DrozdowskiLADixonWTMcBurneyMIThomsonAB. Short-chain fatty acids and total parenteral nutrition affect intestinal gene expression. JPEN J Parenter Enteral Nutr. 2002;26(3):145-150.
67.
FukunagaTSasakiMArakiY. Effects of the soluble fibre pectin on intestinal cell proliferation, fecal short chain fatty acid production and microbial population. Digestion. 2003;67(1-2):42-49.
68.
ParisMCFullerPJCarstensenB. Plasma GLP-2 levels and intestinal markers in the juvenile pig during intestinal adaptation: effects of different diet regimens. Dig Dis Sci. 2004;49(10):1688-1695.
69.
Tolga MuftuogluMACivakTCetinSCivakLGungorOSaglamA. Effects of probiotics on experimental short-bowel syndrome. Am J Surg. 2011;202(4):461-468.
70.
EizaguirreIUrkiaNGAsensioAB. Probiotic supplementation reduces the risk of bacterial translocation in experimental short bowel syndrome. J Pediatr Surg. 2002;37(5):699-702.
71.
KanamoriYHashizumeKSugiyamaMMorotomiMYukiN. Combination therapy with Bifidobacterium breve, Lactobacillus casei, and galactooligosaccharides dramatically improved the intestinal function in a girl with short bowel syndrome: a novel synbiotics therapy for intestinal failure. Dig Dis Sci. 2001;46(9):2010-2016.
72.
KanamoriYSugiyamaMHashizumeKYukiNMorotomiMTanakaR. Experience of long-term synbiotic therapy in seven short bowel patients with refractory enterocolitis. J Pediatr Surg. 2004;39(11):1686-1692.
73.
UchidaKTakahashiTInoueM. Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome. Pediatr Surg Int. 2007;23(3):243-248.
74.
JolyFMayeurCBruneauA. Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome. Biochimie. 2010;92(7):753-761.
75.
TappendenKADeutschAS. The physiological relevance of the intestinal microbiota—contributions to human health. J Am Coll Nutr. 2007;26(6):679S-683S.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
